1Jemal A,Bray F,MM C,et al.Global cancer statistics[J].CA Cancer J Clin,2011,31(2):69-90.
2Autier P,Boniol M,La Vecchia C,et al.Disparities in breast cancer mortality trends between 30 European countries:retrospective trend analysis of WHO mortality database[J].Br Med J 2010,341:c3620.
4Rakha EA,El-Rehim DA,Paish C,et al.Basal phenotype identif ies a poor prognostic subgroup of breast cancer of clinical importance[J].Eur J Cancer,2006,42(18):3149-3156.
5Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor(PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California Cancer Registry[J].Cancer,2007,109(9):1721-1728.
6Brenton JD,Carey LA,Ahmed AA,et al.Molecular classification and molecular forecasting of breast cancer:ready for clinical application?[J].J Clin Oncol,2005,23(29):7350-7360.
7Rauh C,Gass P,Heusinger K,et al.Association of molecular subtypes with breast cancer risk factors:a case-only analysis[J].Eur J Cancer Prev,2015,24(6):484-490.
8Millikan RC,Newman B,Tse CK,et al.Epidemiology of basal-like breast cancer[J].Breast Cancer Res Treat,2008,109(1):123-139.
9Qiu J,Xue X,Hu C,et al.Comparison of Clinicopathological Feat u res and Prog nosis in Tr iple-Negative and Non-Tr iple Negative Breast Cancer[J].J Cancer,2016,7(2):167-173.
10Crabb SJ,Cheang MC,Leung S,et al.Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer[J].Clin Breast Cancer,2008,8(3):249-256.
3Curado MPEB,Shin HR,Storm H,et al. Cancer Inci- dence in Five Continents,Vol. IX [M] . Lyon: IARC Sci- entific Publication,2008. 1-837.
4Felay L, Burkhard C,Whe|an S,et al. Cheek and Conver- sion Programs for Cancer Registries. IARC Technical Re- port No.42[M]. Lyon : IARC, 2005.
5Bray F,Parkin DM. Evaluation of data quality in the can- cer registry:principles and methods. Part I :comparabili- ty, validity and timeliness [J]. Eur J Cancer, 2009,45 (5).. 747-755.
6Parkin DM,Chen VW,Ferlay J,et al. Comparability and Quality Control in Cancer Registration. |ARC Technical Report No.19[M]. Lyon:|ARC, 1994-.
7Felay J. The IARCcrgTools program[EB/OL], http://www.i- acr.com.fr/iarccrgtoo|s.htm.
8Allemani C,Weir HK,Carrira H,et al. Global surveil- lance of cancer survival 1995-2009 :analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)[J]. Lancet,2014, Nov 26.[Epub ahead of print].
9Zeng H,Zheng R,Guo Y,et al. Cancer survival in China, 2003-2005:a popuLation-based study [J]. lnt J Cancer, 2014,Sep20. [Epub ahead of print].
10Chen W,Zheng R,Zhang S,et al. Report of cancer inci- dence and mortality in China,2010 [J]. Ann Transl Med, 2014,2(7):61.
